Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci

被引:38
|
作者
Chun, Sejong [1 ]
Huh, Hee Jae [1 ]
Lee, Nam Yong [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul 135710, South Korea
关键词
Viridans streptococci; Penicillin; Resistance; Microbial; IN-VITRO ACTIVITIES; PENICILLIN-RESISTANT; HEMOLYTIC STREPTOCOCCI; NEUTROPENIC PATIENTS; PNEUMONIAE; IDENTIFICATION; ANTIBIOTICS; INFECTIONS; BACTEREMIA; CHILDREN;
D O I
10.3343/alm.2015.35.2.205
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Viridans group streptococci (VGS) are both commensal microbes and potential pathogens. Increasing resistance to penicillin in VGS is an ongoing issue in the clinical environment. We investigated the difference in susceptibility and resistance to penicillin among various VGS species. Methods: In total 1,448 VGS isolated from various clinical specimens were analyzed over a two-yr period. Identification and antimicrobial susceptibility test was performed by the automated VITEK 2 system (bioMerieux, France) or the Micro Scan MICroSTREP system (Siemens, Germany). Results: Among the 1,448 isolates, 412 were isolated from blood (28.4%). Streptococcus mitis group was the most frequently isolated (589 isolates, 40.7%), followed by the Streptococcus anginosus group (290 isolates, 20.0%), Streptococcus sanguinis group (179 isolates, 12.4%) and Streptococcus salivarius group (57 isolates, 3.9%). In total, 314 isolates could not be identified up to the species level. The overall non-susceptibility to penicillin was observed to be 40.0% (resistant, 11.2% and intermediately resistant, 28.8%) with uneven distribution among groups; 40.2% in Streptococcus sanguinis group (resistant, 5.0% and intermediately resistant, 35.2%), 60.3% in Streptococcus mitis group (resistant, 20.9% and intermediately resistant, 39.4%), 78.9% in Streptococcus salivarius group (resistant, 8.8% and intermediately resistant, 70.1%), and 6.2% in Streptococcus anginosus group (resistant, 1.7% and intermediately resistant, 4.5%). Conclusions: Antimicrobial resistance patterns towards penicillin show differences among various VGS; this should be considered while devising an effective antimicrobial treatment against VGS.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [21] Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis
    Teng, LJ
    Hsueh, PR
    Chen, YC
    Ho, SW
    Luh, KT
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 621 - 627
  • [22] Induction of In Vitro Resistance to Penicillin in Viridans Group Streptococci and Its Effect on Susceptibility Pattern of Other Antimicrobial Agents
    Dhotre, Shree V.
    Nagoba, Basavraj S.
    Suryawanshi, Namdev M.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2016, 5 (02) : 101 - 106
  • [23] Evaluation of the MicroScan MICroSTREP Plus Antimicrobial Panel for Testing β-Hemolytic Streptococci and Viridans Group Streptococci
    Kim, Sung Ju
    Uh, Young
    Jang, In Ho
    Lee, Kwan Soo
    Park, Soon Deok
    Yoon, Kap Jun
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2011, 31 (03): : 185 - 190
  • [24] ANTIMICROBIAL SUSCEPTIBILITY OF GROUP-B STREPTOCOCCI
    BORDERON, JC
    BORDERON, E
    GESLIN, P
    SISSIA, G
    VALLA, M
    PATHOLOGIE BIOLOGIE, 1984, 32 (01): : 35 - 39
  • [25] ANTIMICROBIAL SUSCEPTIBILITY OF GROUP-B STREPTOCOCCI
    PERSSON, KMS
    FORSGREN, A
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 165 - 167
  • [26] ANTIMICROBIAL SUSCEPTIBILITY OF VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM PATIENTS WITH ACUTE-LEUKEMIA RECEIVING OFLOXACIN FOR ANTIBACTERIAL PROPHYLAXIS
    KERN, W
    LINZMEIER, K
    KURRLE, E
    INFECTION, 1989, 17 (06) : 396 - 397
  • [27] Antimicrobial Resistance of Community-acquired Bloodstream Isolates of Viridans Group Streptococci
    R. L. Yap
    L. A. Mermel
    J. Maglio
    Infection, 2006, 34 : 339 - 341
  • [28] Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis
    Marquart, Mary E.
    Benton, Angela H.
    Galloway, Regina C.
    Stempak, Lisa M.
    PLOS ONE, 2018, 13 (12):
  • [29] ANTIMICROBIAL THERAPY OF EXPERIMENTAL ENDOCARDITIS CAUSED BY NUTRITIONALLY VARIANT VIRIDANS GROUP STREPTOCOCCI
    HENRY, NK
    WILSON, WR
    ROBERTS, RB
    ACAR, JF
    GERACI, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) : 465 - 467
  • [30] Identification of clinically relevant viridans group streptococci to the species level by PCR
    Garnier, F
    Gerbaud, G
    Courvalin, P
    Galimand, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) : 2337 - 2341